Provider review
VevaRX review
Four prices on one page, and a tirzepatide plan sold only three months at a time.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated September 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
Prices contradict on the page — $189 to $467 quoted
Visit VevaRXThe semaglutide page carries four figures and two of them belong to tirzepatide. The quarterly plan's own per-month equivalent does not divide.
Price as published
VevaRX
Prices contradict on the page — $189 to $467 quoted
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The reason to read this review is that the pages do not agree with each other on what anything costs. The semaglutide page alone carries four different figures, and two of them are tirzepatide's. Tirzepatide itself is sold only in three-month blocks that auto-renew every three months, with no monthly option on its own page, and the per-month equivalent printed beside the block is wrong by six dollars — the semaglutide page states the correct division for the same number. Three of the peptide products are priced two or three ways each, and in two cases the cart charges a figure the product card never showed. The contradictions run past pricing: the contact page's questions are another product's copy and answer how to take semaglutide with instructions for mixing a powdered drink, and another brand's domain appears in these terms as the site the transactions are conducted on. Coverage is thirty-six states enumerated by name in the questions and all fifty in the terms, twice. No pharmacy, clinician, medical group or compounding class is named anywhere.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the served states enumerated by name rather than claimed as a round number
- You are buying semaglutide month to month, which is the one plan here with a monthly option
Look elsewhere if
- You need to know what you will be charged — the page selling semaglutide carries four different figures
- You want tirzepatide monthly: it is sold only in auto-renewing three-month blocks
- You want copy you can trust on dosing, which on the contact page belongs to a different product entirely
What it actually costs
Price as published
Prices contradict on the page — $189 to $467 quoted
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. No low-dose product is offered, and the prices this seller publishes contradict each other on the page selling them: the semaglutide page carries four figures, two of which belong to tirzepatide, and tirzepatide is sold only in auto-renewing three-month blocks whose printed per-month equivalent does not divide. No figure holds up on its own page well enough to compare.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Enumerates thirty-six states by name in the questions rather than claiming a round number without a list
- The three-month tirzepatide plan states what the total buys — the treatment, the supplies and the provider visit — in one figure
- Semaglutide has a month-to-month option, so at least one molecule is not locked to a quarter
- The auto-renewal cadence and the three-month minimum are stated on the product page rather than only in the terms
- Publishes a refund route for a patient the provider declines at the initial consultation
Pharmacy, labs and oversight
VevaRX does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What VevaRX publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
VevaRX sells compounded semaglutide and compounded tirzepatide as injections alongside sermorelin, NAD+, glutathione and PT-141, and the reason to read the row is that its own pages do not agree on what any of it costs. The semaglutide page alone carries four figures, two of which are tirzepatide's. Tirzepatide is sold only in three-month blocks that auto-renew every three months, and the per-month equivalent printed beside the block is wrong by six dollars — the semaglutide page states the correct division for the same number. Three peptides are priced two or three different ways each, and in two cases the cart charges the figure that is not on the card. The contradictions extend past pricing: the contact page's questions are another product's copy and answer how to take semaglutide with instructions for mixing a powdered drink, and another brand's domain appears in VevaRX's own terms as the site transactions are conducted on. Coverage is enumerated as thirty-six states in the questions while the terms twice assert all fifty. No pharmacy, clinician, medical group or compounding designation is named.
The honest cons
THE SEMAGLUTIDE PAGE CARRIES FOUR PRICES AND TWO OF THEM BELONG TO TIRZEPATIDE, so what a reader would be charged is not resolvable from the page selling it
- The tirzepatide block advertises an equivalent of $149 a month for a $467 quarterly charge, which is $155.67 — and the semaglutide page states that correct figure for the same plan
- Tirzepatide is sold only in three-month blocks that auto-renew every three months, with no monthly option on its page
- Three peptide products are priced two or three different ways each, and in two cases the cart charges a figure the card does not show
- Another brand's domain appears in these terms as the site the transactions are conducted on
- The contact page's questions are a different product's copy and give dosing instructions for a powdered drink under the question about taking semaglutide
- Coverage is thirty-six named states in the questions and all fifty in the terms, twice
- No pharmacy, clinician, medical group or compounding designation is named, and no milligram is published
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
VevaRX is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way VevaRX does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sesame Care
Wegovy pill from $149/mo + sub
Standard plan, self-directed low dose
Partner
RxSpan MD
$249/mo month to month ($199 on 6-mo)
Standard plan, self-directed low dose
Where this sits
#392 of 548
Ordered with the companies that pay us first, and VevaRX is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Microdosing tirzepatide
- What the evidence actually shows
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Direct Meds
From $249/mo sublingual · $297/mo injection
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
- Vs median
- $74/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by CraftedRx · ChemistryRx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Direct Meds review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.